Feasibility and clinical impact of re-biopsy in advanced non small-cell lung cancer: A prospective multicenter study in a real-world setting (GFPC study 12-01)-Reference-Cited by-同舟云学术

Feasibility and clinical impact of re-biopsy in advanced non small-cell lung cancer: A prospective multicenter study in a real-world setting (GFPC study 12-01)

Published:2014-11 Issue:2 Volume:86 Page:170-173
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Chouaid Christos,Dujon Cecile,Do Pascal,Monnet Isabelle,Madroszyk Anne,Le Caer Herve,Auliac Jean Bernard,Berard Henri,Thomas Pascal,Lena Herve,Robinet Gilles,Baize Nathalie,Bizieux-Thaminy Acya,Fraboulet Gislaine,Locher Chrystele,Le Treut Jacques,Hominal Stephane,Vergnenegre Alain

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference19 articles.

1. New pathologic classification of lung cancer: relevance for clinical practice and clinical trials;Travis;J Clin Oncol,2013

2. A systematic review and Canadian consensus recommendations on the use of biomarkers in the treatment of non-small cell lung cancer;Ellis;J Thorac Oncol,2011

3. Peters S, Adjei AA, Gridelli C, et al. ESMO Guidelines Working Group. Metastatic non-small-cell lung cancer (NSCLC): ESMOClinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2012;23:7:vii56-64.

4. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma;Mok;N Engl J Med,2009

5. Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial;Rosell;Lancet Oncol,2012

Cited by 155 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advanced non-squamous NSCLC with no actionable oncogenic driver in Spain: a cross-sectional descriptive analysis of data from the Thoracic Tumor Registry;Clinical and Translational Oncology;2024-06-11

2. Improvement of differential diagnosis of lung cancer by use of multiple protein tumor marker combinations;Tumor Biology;2024-03-19

3. Detection of EGFR T790M mutation using liquid biopsy for non-small cell lung cancer: Utility of droplet digital polymerase chain reaction vs. cobas real-time polymerase chain reaction;Pathology - Research and Practice;2024-03

4. Redetermination of PD-L1 expression after chemio-radiation in locally advanced PDL1 negative NSCLC patients: retrospective multicentric analysis;Frontiers in Oncology;2024-01-31

5. Liquid biopsy as a source of potential biomarkers for checkpoint inhibitor treatment in non-small cell lung cancer;Medicinska istrazivanja;2024